Gpr177 Deficiency Impairs Mammary Development and Prohibits Wnt-Induced Tumorigenesis

Maruyama, Eri Ohfuchi; Yu, H-M. Ivy; Jiang, Ming; Fu, Jiang; Hsu, Wei
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Aberrant regulation of the Wnt pathway, essential for various developmental processes, is tightly linked to human breast cancers. By hijacking this evolutionary conserved signaling pathway, cancer cells acquire sustaining proliferation ability, leading to modification of physiologic properties necessary for tumor initiation and progression. An enormous wealth of knowledge on the importance of Wnt signaling in breast development and cancer has been obtained, but the cell types responsible for production of this proliferative signal operating within normal and malignant tissues remains poorly understood. Here we report that Wnt production mediated by Gpr177 is essential for mammary morphogenesis. The loss of Gpr177 interferes with mammary stem cells, leading to deficiencies in cell proliferation and differentiation. Genetic analysis further demonstrates an indispensable role of Gpr177 in Wnt-induced tumorigenesis. The Gpr177-deficiency mice are resistant to malignant transformation. This study not only demonstrates the necessity of Wnt in mammary organogenesis but also provides a proof-of-principle for targeting of Gpr177 as a potential new treatment for human diseases with aberrant Wnt stimulation.


Related Articles

  • Integrin α3β1-CD151 complex regulates dimerization of ErbB2 via RhoA. Novitskaya, V; Romanska, H; Kordek, R; Potemski, P; Kusińska, R; Parsons, M; Odintsova, E; Berditchevski, F // Oncogene;5/22/2014, Vol. 33 Issue 21, p2779 

    Integrin α3β1 regulates adhesive interactions of cells with laminins and have a critical role in adhesion-dependent cellular responses. Here, we examined the role of α3β1-integrin in ErbB2-dependent proliferation of breast cancer cells in three-dimensional laminin-rich extracellular...

  • Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways. Strong, Amy L.; Strong, Thomas A.; Rhodes, Lyndsay V.; Semon, Julie A.; Xiujuan Zhang; Zhenzhen Shi; Shijia Zhang; Gimble, Jeffrey M.; Burow, Matthew E.; Bunnell, Bruce A. // Breast Cancer Research;2013, Vol. 15 Issue 5, p2 

    Introduction Obesity has been associated with increased incidence and mortality of breast cancer. While the precise correlation between obesity and breast cancer remains to be determined, recent studies suggest that adipose tissue and adipose stem cells (ASCs) influence breast cancer...

  • Simvastatin Impairs Growth Hormone-Activated Signal Transducer and Activator of Transcription (STAT) Signaling Pathway in UMR-106 Osteosarcoma Cells. Sandoval-Usme, María Claudia; Umaña-Pérez, Adriana; Guerra, Borja; Hernández-Perera, Orlando; García-Castellano, José Manuel; Fernández-Pérez, Leandro; Sánchez-Gómez, Myriam // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Recent studies have demonstrated that statins reduce cell viability and induce apoptosis in various types of cancer cells. The molecular mechanisms underlying these effects are poorly understood. The JAK/STAT pathway plays an important role in the regulation of proliferation and apoptosis in...

  • Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression. Chen, Jin; Wang, Feng-Ling; Chen, Wei-Dong // Molecular Biology Reports;Jul2014, Vol. 41 Issue 7, p4583 

    A hallmark of cancer is resistance to apoptosis, with both the loss of proapoptotic signals and the gain of anti-apoptotic mechanisms contributing to tumorigenesis. As inducing apoptosis in malignant cells is one of the most challenging tasks regarding cancer, researchers increasingly focus on...

  • CXCR3 Signaling in BRAFWT Melanoma Increases IL-8 Expression and Tumorigenicity. Jenkins, Molly H.; Brinckerhoff, Constance E.; Mullins, David W. // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    Patients with early stage, radial growth phase (RGP) melanoma have a 97% survival rate; however, when the melanoma progresses to the invasive vertical growth phase (VGP), survival rates decrease to 15%. The targets of many clinical trials are the known genetic and molecular mechanisms involved...

  • Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion. Sundqvist, A; Zieba, A; Vasilaki, E; Herrera Hidalgo, C; Söderberg, O; Koinuma, D; Miyazono, K; Heldin, C-H; Landegren, U; ten Dijke, P; van Dam, H // Oncogene;8/1/2013, Vol. 32 Issue 31, p3606 

    Deregulation of the transforming growth factor β (TGFβ) signal transduction cascade is functionally linked to cancer. In early phases, TGFβ acts as a tumor suppressor by inhibiting tumor cell proliferation, whereas in late phases, it can act as a tumor promoter by stimulating tumor cell...

  • Bioluminescence imaging of estrogen receptor activity during breast cancer progression. Vantaggiato, Cristina; Dell'Omo, Giulia; Ramachandran, Balaji; Manni, Isabella; Radaelli, Enrico; Scanziani, Eugenio; Piaggio, Giulia; Maggi, Adriana; Ciana, Paolo // American Journal of Nuclear Medicine & Molecular Imaging;2016, Vol. 6 Issue 1, p32 

    Estrogen receptors (ER) are known to play an important regulatory role in mammary gland development as well as in its neoplastic transformation. Although several studies highlighted the contribution of ER signaling in the breast transformation, little is known about the dynamics of ER state of...

  • Cancer stemness in Wnt-driven mammary tumorigenesis. Monteiro, Joana; Gaspar, Claudia; Richer, Wilfrid; Franken, Patrick F.; Sacchetti, Andrea; Joosten, Rosalie; Idali, Anouar; Brandao, Joana; Decraene, Charles; Fodde, Riccardo // Carcinogenesis;Jan2014, Vol. 35 Issue 1, p2 

    Wnt signaling plays a central role in mammary stem cell (MaSC) homeostasis and in breast cancer. In particular, epigenetic alterations at different members of the Wnt pathway have been identified among triple-negative, basal-like breast cancers. Previously, we developed a mouse model for...

  • Anticipating mechanisms of resistance to PI3K inhibition in breast cancer: a challenge in the era of precision medicine. Leroy, Cedric; Amante, Romain J.; Bentires-Alj, Mohamed // Biochemical Society Transactions;Aug2014, Vol. 42 Issue 4, p733 

    Frequent subversion of the PI3K (phosphoinositide 3-kinase) pathway during neoplastic transformation contributes to several hallmarks of cancer that result in a competitive advantage for cancer cells. Deregulation of this pathway can be the result of genomic alterations such as PIK3CA mutation,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics